Fortress Biotech, Inc. (FBIOP) to Issue Monthly Dividend of $0.20 on February 29th

Fortress Biotech, Inc. (NASDAQ:FBIOPGet Free Report) declared a monthly dividend on Sunday, February 11th, Wall Street Journal reports. Investors of record on Thursday, February 15th will be paid a dividend of 0.1953 per share on Thursday, February 29th. This represents a $2.34 annualized dividend and a yield of 16.98%. The ex-dividend date of this dividend is Wednesday, February 14th.

Fortress Biotech Price Performance

Shares of NASDAQ FBIOP opened at $13.80 on Monday. The firm’s 50-day moving average price is $12.95 and its two-hundred day moving average price is $12.47. Fortress Biotech has a 52-week low of $6.40 and a 52-week high of $20.25.

Fortress Biotech Company Profile

(Get Free Report)

Fortress Biotech, Inc, a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino an oral minocycline drug for the treatment of moderate to severe acne; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Exelderm cream for antifungal intended for topical use; Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Amzeeq; Zilxi; and Accutane capsules for severe recalcitrant nodular acne.

Further Reading

Dividend History for Fortress Biotech (NASDAQ:FBIOP)

Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.